E.g., 11/27/2024
E.g., 11/27/2024

Hyglos Honored with 2010 Food Safety Innovation Award for Technology Used in bioMérieux's VIDAS® UP E. Coli O157 (Including H7)

29 July, 2010

bioMérieux, a world leader in the field of in vitro diagnostics, and Hyglos GmbH, the leader in applied phage protein technology, today announced that a team of scientists who developed a new diagnostic tool for food microbiologists is the recipient of the 2010 Food Safety Innovation Award given by the International Association of Food Protection (IAFP). Visit www.biomerieux-usa.com or www.biomerieux-usa.com/iafp2010.

bioMérieux - First-Half 2010 Business Review

22 July, 2010

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2010.

Lab Informatics Expert Joins bioMérieux

19 July, 2010

A world leader in in vitro diagnostics, bioMérieux today announced the appointment of Jacques L. Baudin as Vice President, Commercial Operations Information Technology.

bioMérieux's TEMPO® STA Assay Gains International Approvals for Food Safety Testing

07 June, 2010

tempo_sta_thumb16.jpg AFNOR/ISO and AOAC Research Institute validate performance of automated food safety solution. bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce that TEMPO® STA, an automated quality indicator test for the fast enumeration of Staphylococcus aureus in food products, has been approved by both the AFNOR Validation according to the ISO 16140 norm, and the AOAC Research Institute. The rigors of these third party validations provide food professionals with added assurance for high performance testing standards.

Data from Clinical Studies of bioTheranostics' CancerTYPE ID® and Breast Cancer Index® Molecular Oncology Test Presented at ASCO 2010 Annual Meeting*

06 June, 2010

bioTheranostics, a bioMérieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from clinical studies utilizing the company’s CancerTYPE ID® and Breast Cancer Index® molecular oncology tests. Data from the studies were presented this week at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting in Chicago.

bioMérieux Showcases Myla® at ASM 2010: New Informatics Solution to Transform the Microbiology Laboratory

25 May, 2010

Innovative solution optimizes laboratory workflow and clinical information management

bioMérieux Extends Portfolio of Full Micriobiology Lab Automation solutions at ASM General Meeting

24 May, 2010

bioMérieux, a world leader in the field of in vitro diagnostics, today announced that it will present an expanded portfolio of microbiology laboratory automation solutions during the 110th General Meeting of the American Society for Microbiology (ASM) in San Diego, Calif.

bioMérieux Presents 2010 Sonnenwirth Award for Leadership in Clinical Microbiology to Patricia Charache

24 May, 2010

Charache to Give Accompanying Lecture during the American Society for Microbiology General Meeting on May 24th in San Diego

Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Micriobiology

21 May, 2010

Shimadzu and bioMérieux announce today that they have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology laboratories.

bioMérieux Co-Sponsors French Medical Days in Shanghai

17 May, 2010

bioMérieux plays a driving role in Sino-French healthcare cooperation: · Organization of seminar on emergency medicine · Inauguration of Sino-French Emergency Satellite Lab at Xinhua Hospital · Renewal and extension of the partnership with Fudan University Shanghai Cancer Hospital · Pilot project with the Shanghai Health Bureau on decentralized diagnostics in Community and County Healthcare Centers (CHC)

Pioneering Diagnostics